Document Detail


Beneficial effects of tea and its polyphenols against prostate cancer.
MedLine Citation:
PMID:  16425281     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Tea, next to water, is the most widely consumed beverage in the world. Depending upon the level of fermentation, tea can be categorized into three types: green (unfermented), oolong (partially fermented), and black (highly to fully fermented). In general, green tea has been found to be superior to black and oolong tea in terms of antioxidant and health promoting benefits owing to the higher content of (-)-epigallocatechin-3-gallate. Tea polyphenols comprise about one-third of the weight of the dried leaf, and they exhibit biochemical and pharmacological activities including antioxidant activities, inhibition of cell proliferation, induction of apoptosis, cell cycle arrest and modulation of carcinogen metabolism. Several studies demonstrate that most tea polyphenols exert their effects by scavenging reactive oxygen species (ROS) since excessive production of ROS has been implicated in the development of a variety of ailments including cancer of the prostate gland (CaP). Using cell culture and animal model systems, molecular targets for these remarkable beneficial effects of green tea drinking on CaP prevention and therapy have been defined. Geographical and case-control studies are showing that green tea drinking could afford CaP chemopreventive effects in human population. In this review we attempt to summarize the experimental as well as the epidemiological basis for the possible role of tea and its polyphenols for chemoprevention and chemotherapy of CaP.
Authors:
Imtiaz A Siddiqui; Vaqar M Adhami; Mohammad Saleem; Hasan Mukhtar
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural; Review    
Journal Detail:
Title:  Molecular nutrition & food research     Volume:  50     ISSN:  1613-4125     ISO Abbreviation:  Mol Nutr Food Res     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-02-13     Completed Date:  2006-04-27     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  101231818     Medline TA:  Mol Nutr Food Res     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  130-43     Citation Subset:  IM    
Affiliation:
Department of Dermatology, University of Wisconsin, Medical Sciences Center, Madison, WI 53706, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Androgens / metabolism
Animals
Apoptosis / drug effects
Catechin / analogs & derivatives,  analysis
Cell Cycle / drug effects
Clinical Trials as Topic
Fermentation
Flavonoids / administration & dosage*,  analysis
Gene Expression / drug effects
Humans
Male
Neoplasm Transplantation
Neovascularization, Pathologic / prevention & control
Phenols / administration & dosage*,  analysis
Polyamines / metabolism
Prostate-Specific Antigen / blood
Prostatic Neoplasms / blood supply,  prevention & control*
Signal Transduction / drug effects
Tea / chemistry*
Grant Support
ID/Acronym/Agency:
P50 DK065303-01/DK/NIDDK NIH HHS; R01 CA 101039/CA/NCI NIH HHS; R01 CA 78809/CA/NCI NIH HHS
Chemical
Reg. No./Substance:
0/Androgens; 0/Flavonoids; 0/Phenols; 0/Polyamines; 0/Tea; 0/polyphenols; 154-23-4/Catechin; 989-51-5/epigallocatechin gallate; EC 3.4.21.77/Prostate-Specific Antigen

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Possible mechanisms of the cancer-preventive activities of green tea.
Next Document:  Chemoprevention of lung cancer by tea.